The Latest: Regulators OK COVID-19 treatment's emergency use

WASHINGTON-- Federal regulators have authorized emergency use of another COVID-19 treatment, the anti-inflammatory drug baricitinib, to be used in combination with a drug already used to treat severely ill, hospitalized patients.

Become a Subscriber!

You have read all of your free articles this month. Select a plan below to start your subscription today.

Already a subscriber? Login

Sign In

Print & Digital

Includes home delivery and FREE digital access when you sign up with EZ Pay

• $16.25 per month

Buy

Unlimited Digital Access

*Access via computer, tablet, or mobile device

• $9.95 per month

Buy

Click here for more options